Medical device manufacturer St. Jude Medical reported that has received Food and Drug Administration clearance for its Angio-Seal VIP vascular closure device.
The new device, which is approved for both diagnostic and interventional procedures, includes a small anchor, collagen, and a suture, according to the St. Paul, MN-based developer. All components of the Angio-Seal VIP are fully absorbed within 60 to 90 days, so no foreign material permanently remains in the body, the company said.
The device also has received European CE Mark approval, St. Jude said.
By AuntMinnie.com staff writers
March 17, 2006
Related Reading
St. Jude successful with US cardiac ablation, December 21, 2004
Copyright © 2006 AuntMinnie.com
